Lv1
30 积分 2024-09-06 加入
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
1个月前
已完结
Metabolic Checkpoints in IgA Nephropathy: From Pathogenesis to Precision Medicine
1个月前
已完结
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
1个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
1个月前
已完结
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
2个月前
已完结
The role of lipotoxicity in kidney disease: From molecular mechanisms to therapeutic prospects
2个月前
已完结
Insulin resistance in chronic kidney disease: a systematic review
2个月前
已完结
Kidney disease and obesity: epidemiology, mechanisms and treatment
2个月前
已完结
Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study
2个月前
已完结
Metabolic syndrome
2个月前
已完结
皖公网安备34019202002308
